TEZ/IVA

tezacaftor/ivacaftor · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TEZ/IVA, covering 2020-02-11 to 2021-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Long-term Treatment With TEZ/IVA in CF Participants With an F508del CFTR Mutation [Phase 3]

See pricing